share_log

Twist Bioscience Q4 2024 GAAP EPS $(0.59) Beats $(0.70) Estimate, Sales $84.71M Beat $82.20M Estimate

Twist Bioscience Q4 2024 GAAP EPS $(0.59) Beats $(0.70) Estimate, Sales $84.71M Beat $82.20M Estimate

twist bioscience 2024 財年第四季度 GAAP 每股收益 $(0.59) 超過 $(0.70) 的預期,銷售額 $8471萬 超過 $8220萬 的預期
Benzinga ·  11/18 20:17

Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.70) by 15.71 percent. This is a 27.16 percent increase over losses of $(0.81) per share from the same period last year. The company reported quarterly sales of $84.71 million which beat the analyst consensus estimate of $82.20 million by 3.05 percent. This is a 26.53 percent increase over sales of $66.95 million the same period last year.

twist bioscience(納斯達克:TWST)報告季度每股虧損$(0.59),超出分析師共識預期$(0.70),增幅達15.71%。與去年同期每股$(0.81)的虧損相比,增長了27.16%。公司報告季度銷售額爲8471萬美元,超出分析師共識預期的8220萬美元,增幅達3.05%。與去年同期的6695萬美元銷售額相比,增長了26.53%。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論